Recent

% | $
Quotes you view appear here for quick access.

Titan Pharmaceuticals Inc. Message Board

  • tables777 tables777 Mar 5, 2013 9:24 AM Flag

    Interested in buying but I have a question

    The chances are good for approval, but why the selloff in recent weeks from a high of $2.40? Is there more uncertainty here? If so, what is it?

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Agree with much of what is said here. The bottom line is the long term trend is way better than the short term selling pressure from earlier share and warrant overhang. In the end, these short term sell offs have provided you with an opportunity to get in at a cheaper price then would have been otherwise possible. Titan has great phase 3 results, a great partner deal in place, an innovative product in a space where such innovation is really needed that treats a disease that is growing exponentially in awareness. There are risks, no doubt. The biggest being the obvious, they get shot down by the fda. While many here discount that fact because it is an already approved drug and is being used to treat a high priority fda topic, it still is the fda and this is still a complicated approval process since it involves a scheduled drug and a surgery to put the implants in. I do believe even if there is an initial rejection will be met with eventual approval within a year.

      Sentiment: Buy

    • Volatility of fickle traders in a low volume market. First, the initial sell off to take profits. And now, its a low volume stock reacting to being sold off by traders wanting to get into better performing pharmas for the time being. Pick your entry point and then be patient, if you like this one.

    • The drop from $2.40 was your normal 25% correction after a huge run up.

      There are no .85 holders. They are long gone. Their short sales caused the initial calamity as they pounded the pps down to .60. If you look at the institutional holdings, there are no new institutions. The Rodman hedgies shorted and covered with the discounted .85 shares. Sianara! They still hold long term $1.15 warrants but its unlikely that they would be selling now and foregoing the time premium.

    • Some traders have taken profits. Holders are waiting for the next catalysts to occur - the Advisory Committee meeting and report and approval from the FDA.

    • We have warrants holders at 1.15 who hold an equal amount of shares at 85. Why hold the shares at 85 (when they are up over 100%) when you have risk free warrants at 1.15?

      They are selling their shares. It is smart business from people who are paid to get a return on other people's money. They don't think the same way we do...which is probably a good thing.

 
TTNP
3.4096+0.0096(+0.28%)12:33 PMEST